BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17709575)

  • 21. [Clinical characteristics and incidence of infectious and non-infectious endophthalmitis after intravitreous injection of triamcinolone acetonide].
    Magalhães E; Nehemy P; Santos DV; Fujji G; Nehemy MB
    Arq Bras Oftalmol; 2006; 69(6):791-4. PubMed ID: 17273669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudohypopyon following intravitreal triamcinolone acetonide injection.
    Sharma MC; Lai WW; Shapiro MJ
    Cornea; 2004 May; 23(4):398-9. PubMed ID: 15097137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravitreal injections of corticoids].
    Demols P
    Bull Soc Belge Ophtalmol; 2007; (304):117-23. PubMed ID: 17718236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse intraocular dispersion of triamcinolone particles as a cause of sterile endophthalmitis.
    Chen SD; Lochhead J; Patel CK
    Arch Ophthalmol; 2004 Nov; 122(11):1733; author reply 1733. PubMed ID: 15534152
    [No Abstract]   [Full Text] [Related]  

  • 25. [Survey of triamcinolone-related non-infectious endophthalmitis].
    Sakamoto T; Ishibashi T; Ogura Y; Shiraga F; Takeuchi S; Yamashita H;
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):523-8. PubMed ID: 21735756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudo-endophthalmitis after intravitreal injection of triamcinolone.
    Sutter FK; Gillies MC
    Br J Ophthalmol; 2003 Aug; 87(8):972-4. PubMed ID: 12881337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection.
    Lorenzo Carrero J; González Barcia M; Pérez Flores I
    Arch Ophthalmol; 2008 Jan; 126(1):142-3. PubMed ID: 18195239
    [No Abstract]   [Full Text] [Related]  

  • 28. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Jonas JB; Kreissig I; Spandau UH; Harder B
    Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subconjunctival triamcinolone acetonide injection in the treatment of acute noninfectious nonnecrotizing anterior scleritis.
    Onal S; Asfuroglu E; Kazokoglu H
    Am J Ophthalmol; 2010 Jun; 149(6):1012; author reply 1012-3. PubMed ID: 20510689
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].
    Jaissle GB; Szurman P; Bartz-Schmidt KU
    Ophthalmologe; 2004 Feb; 101(2):121-8. PubMed ID: 14991307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
    Dyer D; Callanan D; Bochow T; Abraham P; Lambert HM; Lee SY; Schneiderman T; Potts SL; Walker TM
    Retina; 2009 Jan; 29(1):38-45. PubMed ID: 18827733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Tay-Kearney ML
    Ocul Immunol Inflamm; 2006 Aug; 14(4):201-2. PubMed ID: 16911980
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravitreal triamcinolone acetonide in the treatment of ophthalmic inflammatory diseases with macular edema: a meta-analysis study.
    Bucolo C; Grosso G; Drago V; Gagliano C
    J Ocul Pharmacol Ther; 2015 May; 31(4):228-40. PubMed ID: 25825799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ophthalmologic utilization of triamcinolone diacetate in local injections].
    Ardouin M; Garnier JP; Lefranc J
    Bull Soc Ophtalmol Fr; 1967 Sep; 67(9):786-97. PubMed ID: 5630301
    [No Abstract]   [Full Text] [Related]  

  • 35. Sub-tenon triamcinolone acetonide injection in the treatment of scleritis.
    Park YH
    Am J Ophthalmol; 2010 Jul; 150(1):128; author reply 128-9. PubMed ID: 20609711
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):526-7. PubMed ID: 16187987
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety profile of intravitreal triamcinolone acetonide.
    Baath J; Ells AL; Crichton A; Kherani A; Williams RG
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):304-10. PubMed ID: 17593015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases].
    Klitgaard TL; Haamann PH; Villumsen JE; Larsen M
    Ugeskr Laeger; 2005 Apr; 167(16):1729-31. PubMed ID: 15898599
    [No Abstract]   [Full Text] [Related]  

  • 39. Pseudohypopyon after management of posterior capsule rupture using intracameral triamcinolone injection in cataract surgery.
    Lee SJ; Kim YD; Kyung H
    Korean J Ophthalmol; 2014 Aug; 28(4):356-7. PubMed ID: 25120348
    [No Abstract]   [Full Text] [Related]  

  • 40. Endophthalmitis after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring RF
    Arch Ophthalmol; 2003 Nov; 121(11):1663-4. PubMed ID: 14609940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.